Innova Captab’s board has approved a brownfield expansion of the existing Baddi manufacturing facility situated at Jharmajri, Baddi, Himachal Pradesh, within the same premises. The company plans to add 2 oral solid dosage (Tablets/Capsules) production lines with an investment of around Rs 45 crore. The proposed capacity is expected to be completed within approximately 18 to 22 months.
The proposed expansion project will be financed through a combination of bank credit facilities and company's internal accruals. This capacity addition is expected to increase production capacity, improve operational efficiency, optimize manufacturing costs, and support the company's long-term growth and business expansion strategy. The Board of Directors of the company at its meeting held on August 21, 2026 has approved the same.
Innova Captab is engaged in the business of manufacturing and trading of drugs and pharmaceuticals.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1909.90 |
| Dr. Reddys Labs. | 1194.50 |
| Cipla | 1435.00 |
| Lupin | 2190.00 |
| Zydus Lifesciences | 1101.00 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: